These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14975518)

  • 1. Is androgenic alopecia a result of endocrine effects on the vasculature?
    Hernandez BA
    Med Hypotheses; 2004; 62(3):438-41. PubMed ID: 14975518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgenic alopecia: a counterproductive outcome of the anabolic effect of androgens.
    Soni VK
    Med Hypotheses; 2009 Sep; 73(3):420-6. PubMed ID: 19477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
    Ryu HK; Kim KM; Yoo EA; Sim WY; Chung BC
    Br J Dermatol; 2006 Apr; 154(4):730-4. PubMed ID: 16536818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors.
    English RS
    Med Hypotheses; 2018 Feb; 111():73-81. PubMed ID: 29407002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased scalp skin and serum 5 alpha-reductase reduced androgens in a man relevant to the acquired progressive kinky hair disorder and developing androgenetic alopecia.
    Boudou P; Reygagne P
    Arch Dermatol; 1997 Sep; 133(9):1129-33. PubMed ID: 9301590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness.
    Hamada K; Randall VA
    Br J Dermatol; 2006 Apr; 154(4):609-18. PubMed ID: 16536801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baldness may be caused by the weight of the scalp: gravity as a proposed mechanism for hair loss.
    Ustuner ET
    Med Hypotheses; 2008 Oct; 71(4):505-14. PubMed ID: 18667278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptives.
    Wiegratz I; Kuhl H
    Treat Endocrinol; 2002; 1(6):372-86. PubMed ID: 15832490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of female androgenic alopecia with dutasteride.
    Olszewska M; Rudnicka L
    J Drugs Dermatol; 2005; 4(5):637-40. PubMed ID: 16167423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female pattern hair loss may be triggered by low oestrogen to androgen ratio.
    Riedel-Baima B; Riedel A
    Endocr Regul; 2008 Mar; 42(1):13-6. PubMed ID: 18333699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalp reduction in the treatment of androgenic alopecia.
    Norwood OT
    Dermatol Clin; 1987 Jul; 5(3):531-44. PubMed ID: 3301111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome?
    Starka L; Duskova M; Cermakova I; Vrbiková J; Hill M
    Endocr Regul; 2005 Dec; 39(4):127-31. PubMed ID: 16552990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgenic alopecia may have evolved to protect men from prostate cancer by increasing skin exposure to ultraviolet radiation.
    Kabai P
    Med Hypotheses; 2008; 70(5):1038-40. PubMed ID: 17910907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of androgen receptor coactivator ARA70/ELE1 in androgenic alopecia.
    Lee P; Zhu CC; Sadick NS; Diwan AH; Zhang PS; Liu JS; Prieto VG
    J Cutan Pathol; 2005 Sep; 32(8):567-71. PubMed ID: 16115056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Big head? Bald head! Skull expansion: alternative model for the primary mechanism of AGA.
    Taylor PJ
    Med Hypotheses; 2009 Jan; 72(1):23-8. PubMed ID: 18789604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female pattern hair loss, sebum excretion and the end-organ response to androgens.
    Birch MP; Lashen H; Agarwal S; Messenger AG
    Br J Dermatol; 2006 Jan; 154(1):85-9. PubMed ID: 16403099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgenic alopecia.
    Bergfeld WF; Redmond GP
    Dermatol Clin; 1987 Jul; 5(3):491-500. PubMed ID: 3301107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TGF-beta2 in the human hair cycle.
    Hibino T; Nishiyama T
    J Dermatol Sci; 2004 Jun; 35(1):9-18. PubMed ID: 15194142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles.
    Randall VA; Jenner TJ; Hibberts NA; De Oliveira IO; Vafaee T
    J Endocrinol; 2008 Apr; 197(1):11-23. PubMed ID: 18372228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of androgenetic alopecia.
    Rebora A
    J Am Acad Dermatol; 2004 May; 50(5):777-9. PubMed ID: 15097964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.